XML 52 R26.htm IDEA: XBRL DOCUMENT v3.20.1
Financial Instruments (Tables)
3 Months Ended
Mar. 31, 2020
Fair Value Disclosures [Abstract]  
Available-for-sale debt securities
The following tables summarize our debt securities, for which we did not elect the fair value option, by significant investment categories as of December 31, 2019 and March 31, 2020 (in millions):
 As of December 31, 2019
 Adjusted
Cost
Gross
Unrealized
Gains
Gross
Unrealized
Losses
Fair
Value
Cash and Cash
Equivalents
Marketable
Securities
Level 2:
Time deposits(1)
$2,294  $ $ $2,294  $2,294  $ 
Government bonds55,033  434  (30) 55,437  4,518  50,919  
Corporate debt securities27,164  337  (3) 27,498  44  27,454  
Mortgage-backed and asset-backed securities19,453  96  (41) 19,508   19,508  
Total$103,944  $867  $(74) $104,737  $6,856  $97,881  

 As of March 31, 2020
 Adjusted
Cost
Gross
Unrealized
Gains
Gross
Unrealized
Losses
Fair
Value
Cash and Cash
Equivalents
Marketable
Securities
(unaudited)
Level 2:
Time deposits(1)
$2,195  $ $ $2,195  $2,195  $ 
Government bonds50,350  1,162  (50) 51,462  3,668  47,794  
Corporate debt securities26,545  154  (360) 26,339  13  26,326  
Mortgage-backed and asset-backed securities18,576  287  (91) 18,772   18,772  
Total$97,666  $1,603  $(501) $98,768  $5,876  $92,892  
(1)The majority of our time deposits are domestic deposits.
Investments by maturity date
The following table summarizes the estimated fair value of our investments in marketable debt securities with stated contractual maturity dates, accounted for as available-for-sale securities and classified by the contractual maturity date of the securities (in millions, unaudited):
As of
March 31, 2020
Due in 1 year$24,209  
Due in 1 year through 5 years54,662  
Due in 5 years through 10 years3,080  
Due after 10 years12,820  
Total$94,771  
Schedule of unrealized loss on debt securities
The following tables present fair values and gross unrealized losses recorded to AOCI as of December 31, 2019 and March 31, 2020, aggregated by investment category and the length of time that individual securities have been in a continuous loss position (in millions):
 As of December 31, 2019
 Less than 12 Months12 Months or GreaterTotal
 Fair ValueUnrealized
Loss
Fair ValueUnrealized
Loss
Fair ValueUnrealized
Loss
Government bonds$6,752  $(20) $4,590  $(10) $11,342  $(30) 
Corporate debt securities1,665  (2) 978  (1) 2,643  (3) 
Mortgage-backed and asset-backed securities4,536  (13) 2,835  (28) 7,371  (41) 
Total$12,953  $(35) $8,403  $(39) $21,356  $(74) 

 As of March 31, 2020
 Less than 12 Months12 Months or GreaterTotal
 Fair ValueUnrealized
Loss
Fair ValueUnrealized
Loss
Fair ValueUnrealized
Loss
(unaudited)
Government bonds$4,168  $(50) $79  $ $4,247  $(50) 
Corporate debt securities15,561  (232) 113  (1) 15,674  (233) 
Mortgage-backed and asset-backed securities4,796  (85) 326  (6) 5,122  (91) 
Total$24,525  $(367) $518  $(7) $25,043  $(374) 
Gains and losses on equity securities
Gains and losses reflected in other income (expense), net, for our marketable and non-marketable equity securities are summarized below (in millions, unaudited):
Three Months Ended
March 31,
 20192020
Net gain (loss) on equity securities sold during the period$42  $171  
Net unrealized gain (loss) on equity securities held as of the end of the period(1)
1,041  (985) 
Total gain (loss) recognized in other income (expense), net$1,083  $(814) 
(1)Includes net gain of $390 million and net loss of $948 million related to non-marketable equity securities for the three months ended March 31, 2019 and 2020, respectively.
Cumulative net gains on equity securities sold
Equity Securities Sold During the Three Months Ended March 31,
 20192020
Total sale price$240  $909  
Total initial cost120  261  
Cumulative net gains$120  $648  
Summary of unrealized gains and losses for marketable and non-marketable equity securities The carrying values for our marketable and non-marketable equity securities are summarized below (in millions):
As of December 31, 2019
Marketable SecuritiesNon-Marketable SecuritiesTotal
Total initial cost$1,935  $8,297  $10,232  
Cumulative net gain(1)
1,361  3,056  4,417  
Carrying value$3,296  $11,353  $14,649  
(1)Non-marketable securities cumulative net gain is comprised of $3.5 billion unrealized gains and $445 million unrealized losses (including impairment).
As of March 31, 2020
Marketable SecuritiesNon-Marketable SecuritiesTotal
(unaudited)
Total initial cost$1,865  $8,777  $10,642  
Cumulative net gain(1)
949  2,006  2,955  
Carrying value$2,814  $10,783  $13,597  
(1)Non-marketable securities cumulative net gain is comprised of $3.8 billion unrealized gains and $1.7 billion unrealized losses (including impairment).
Marketable equity securities
The following table summarizes marketable equity securities measured at fair value by significant investment categories as of December 31, 2019 and March 31, 2020 (in millions):
 As of December 31, 2019As of March 31, 2020
 Cash and Cash EquivalentsMarketable
Securities
Cash and Cash EquivalentsMarketable
Securities
(unaudited)
Level 1:
Money market funds$4,604  $ $6,806  $ 
Marketable equity securities(1)
 3,046   2,592  
4,604  3,046  6,811  2,592  
Level 2:
Mutual funds 250  89  222  
Total$4,604  $3,296  $6,900  $2,814  
(1) The balances as of December 31, 2019 and March 31, 2020 include investments that were reclassified from non-marketable equity securities following the initial public offering of the issuers.
Summary of unrealized gains and losses for non-marketable equity securities
The following is a summary of unrealized gains and losses recorded in other income (expense), net, and included as adjustments to the carrying value of non-marketable equity securities (in millions, unaudited):
Three Months Ended
March 31,
20192020
Unrealized gains$456  $356  
Unrealized losses (including impairment)(66) (1,304) 
Total unrealized gain (loss) for non-marketable equity securities$390  $(948) 
Schedule of gross notional amounts of derivative instruments
The gross notional amounts of our outstanding derivative instruments were as follows (in billions):
As of December 31, 2019As of March 31, 2020
(unaudited)
Derivatives Designated as Hedging Instruments:
Foreign exchange contracts
    Cash flow hedges $13.2  $12.6  
    Fair value hedges$0.5  $0.5  
    Net investment hedges$9.3  $9.3  
Derivatives Not Designated as Hedging Instruments:
Foreign exchange contracts$43.5  $30.9  
Other contracts$0.1  $1.1  
Schedule of derivative instruments
The fair values of our outstanding derivative instruments were as follows (in millions):
  As of December 31, 2019
  
Balance Sheet LocationFair Value of Derivatives Designated as Hedging InstrumentsFair Value of
Derivatives Not
Designated as
Hedging Instruments
Total Fair Value
Derivative Assets:
Level 2:
Foreign exchange contractsOther current and non-current assets$91  $253  $344  
Other ContractsOther current and non-current assets   
Total$91  $254  $345  
Derivative Liabilities:
Level 2:
Foreign exchange contractsAccrued expenses and other liabilities, current and non-current$173  $196  $369  
Other ContractsAccrued expenses and other liabilities, current and non-current 13  13  
Total $173  $209  $382  

  As of March 31, 2020
  
Balance Sheet LocationFair Value of
Derivatives
Designated as
Hedging Instruments
Fair Value of
Derivatives Not
Designated as
Hedging Instruments
Total Fair Value
(unaudited)
Derivative Assets:
Level 2:
Foreign exchange contractsOther current and non-current assets$394  $103  $497  
Other contractsOther current and non-current assets   
Total$394  $110  $504  
Derivative Liabilities:
Level 2:
Foreign exchange contractsAccrued expenses and other liabilities, current and non-current$43  $94  $137  
Other contractsAccrued expenses and other liabilities, current and non-current 49  49  
Total $43  $143  $186  
Schedule of gain (loss) on derivative instruments
The gains (losses) on derivatives in cash flow hedging and net investment hedging relationships recognized in other comprehensive income ("OCI") are summarized below (in millions, unaudited):
 Gains (Losses) Recognized in OCI on Derivatives Before Tax Effect
Three Months Ended
 March 31,
20192020
Derivatives in Cash Flow Hedging Relationship:
Foreign exchange contracts
Amount included in the assessment of effectiveness$(6) $412  
Amount excluded from the assessment of effectiveness(30) 52  
Derivatives in Net Investment Hedging Relationship:
Foreign exchange contracts
Amount included in the assessment of effectiveness64  80  
Total$28  $544  
 The effect of derivative instruments on income is summarized below (in millions, unaudited):
 Gains (Losses) Recognized in Income
Three Months Ended
 March 31,
20192020
RevenuesOther income (expense), netRevenuesOther income (expense), net
Total amounts presented in the Consolidated Statements of Income in which the effects of cash flow and fair value hedges are recorded$36,339  $1,538  $41,159  $(220) 
Gains (Losses) on Derivatives in Cash Flow Hedging Relationship:
Foreign exchange contracts
Amount of gains (losses) reclassified from AOCI to income$128  $ $26  $ 
Amount excluded from the assessment of effectiveness recognized in earnings based on an amortization approach  23   
Gains (Losses) on Derivatives in Fair Value Hedging Relationship:
Foreign exchange contracts
Hedged items 22   (17) 
Derivatives designated as hedging instruments (22)  17  
Amount excluded from the assessment of effectiveness 10    
Gains (Losses) on Derivatives in Net Investment Hedging Relationship:
Foreign exchange contracts
Amount excluded from the assessment of effectiveness 54   78  
Gains (Losses) on Derivatives Not Designated as Hedging Instruments:
Foreign exchange contracts (249)  229  
Other Contracts 0 (28) 
Total gains (losses)$137  $(185) $49  $280  
Offsetting assets
Offsetting of Assets
As of December 31, 2019
Gross Amounts Not Offset in the Consolidated Balance Sheets, but Have Legal Rights to Offset
Gross Amounts of Recognized AssetsGross Amounts Offset in the Consolidated Balance SheetsNet Presented in the Consolidated Balance SheetsFinancial Instruments Cash Collateral ReceivedNon-Cash Collateral ReceivedNet Assets Exposed
Derivatives$365  $(21) $344  $(88) 
(1)
$(234) $ $22  
As of March 31, 2020
Gross Amounts Not Offset in the Consolidated Balance Sheets, but Have Legal Rights to Offset
Gross Amounts of Recognized AssetsGross Amounts Offset in the Consolidated Balance SheetsNet Presented in the Consolidated Balance SheetsFinancial InstrumentsCash Collateral ReceivedNon-Cash Collateral ReceivedNet Assets Exposed
(unaudited)
Derivatives$588  $(84) $504  $(115) 
(1)
$(326) $(27) $36  
(1)The balances as of December 31, 2019 and March 31, 2020 were related to derivative liabilities which are allowed to be net settled against derivative assets in accordance with our master netting agreements.
Offsetting liabilities
Offsetting of Liabilities
As of December 31, 2019
Gross Amounts Not Offset in the Consolidated Balance Sheets, but Have Legal Rights to Offset
Gross Amounts of Recognized LiabilitiesGross Amounts Offset in the Consolidated Balance SheetsNet Presented in the Consolidated Balance SheetsFinancial Instruments Cash Collateral PledgedNon-Cash Collateral PledgedNet Liabilities
Derivatives$390  $(21) $369  $(88) 
(2)
$ $ $281  
As of March 31, 2020
Gross Amounts Not Offset in the Consolidated Balance Sheets, but Have Legal Rights to Offset
Gross Amounts of Recognized LiabilitiesGross Amounts Offset in the Consolidated Balance SheetsNet Presented in the Consolidated Balance SheetsFinancial Instruments Cash Collateral PledgedNon-Cash Collateral PledgedNet Liabilities
(unaudited)
Derivatives$270  $(84) $186  $(115) 
(2)
$ $(8) $63  
(2) The balances as of December 31, 2019 and March 31, 2020 were related to derivative assets which are allowed to be net settled against derivative liabilities in accordance with our master netting agreements.